Peak expiratory flow variability and exercise responsiveness in methacholine-hyperresponsive adolescents with asthma remission

Yull Koh Young, Hee Kang, Young Yoo, Jinho Yu, Min Nah Kyu, Keun Kim Chang

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The aim of this study was to investigate whether bronchial hyperresponsiveness in adolescents with long-term asthma remission is associated with increased peak expiratory flow (PEF) variability and/or increased bronchial response to exercise (BRE). Twenty-nine adolescents with asthma remission (neither symptoms nor any medication used during the previous two years), but with persistent methacholine hyperresponsiveness (PC20 < 18 mg/mL; remission group), 29 methacholine PC20-matched adolescents with symptomatic asthma (symptomatic group), and 20 healthy subjects (control group) were studied. Subjects recorded PEF twice daily for 14 days and PEF variability, expressed as amplitude % mean, was calculated. Subjects also underwent a standardized exercise challenge; BRE was defined as a maximal % fall in FEV1 within 30 min after exercise. The mean (± SD) PEF variations in the symptomatic group and in the remission group were 12.10 ± 6.35% and 10.02 ± 4.73%, respectively, which were significantly higher than that (5.94 ± 2.44%) of the control group. On the other hand, the degree of BRE (7.36 ± 3.85%) in the remission group was significantly lower than that (22.31 ± 10.50%) of the symptomatic group, and similar to that (5.98 ± 2.70%) of the control group. Methacholine hyperresponsiveness in asthma remission during adolescence is associated with increased PEF variability but not with increased BRE.

Original languageEnglish
Pages (from-to)17-23
Number of pages7
JournalJournal of Asthma
Volume42
Issue number1
DOIs
Publication statusPublished - 2005 Mar 29
Externally publishedYes

Fingerprint

Methacholine Chloride
Asthma
Exercise
Control Groups
Healthy Volunteers

Keywords

  • Adolescence
  • Asthma
  • Bronchial hyperresponsiveness
  • Clinical remission
  • Exercise challenge
  • Peak expiratory flow variability

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Immunology and Allergy
  • Pulmonary and Respiratory Medicine

Cite this

Peak expiratory flow variability and exercise responsiveness in methacholine-hyperresponsive adolescents with asthma remission. / Young, Yull Koh; Kang, Hee; Yoo, Young; Yu, Jinho; Kyu, Min Nah; Chang, Keun Kim.

In: Journal of Asthma, Vol. 42, No. 1, 29.03.2005, p. 17-23.

Research output: Contribution to journalArticle

Young, Yull Koh ; Kang, Hee ; Yoo, Young ; Yu, Jinho ; Kyu, Min Nah ; Chang, Keun Kim. / Peak expiratory flow variability and exercise responsiveness in methacholine-hyperresponsive adolescents with asthma remission. In: Journal of Asthma. 2005 ; Vol. 42, No. 1. pp. 17-23.
@article{092c060b8b504ce5a91ca784a099038e,
title = "Peak expiratory flow variability and exercise responsiveness in methacholine-hyperresponsive adolescents with asthma remission",
abstract = "The aim of this study was to investigate whether bronchial hyperresponsiveness in adolescents with long-term asthma remission is associated with increased peak expiratory flow (PEF) variability and/or increased bronchial response to exercise (BRE). Twenty-nine adolescents with asthma remission (neither symptoms nor any medication used during the previous two years), but with persistent methacholine hyperresponsiveness (PC20 < 18 mg/mL; remission group), 29 methacholine PC20-matched adolescents with symptomatic asthma (symptomatic group), and 20 healthy subjects (control group) were studied. Subjects recorded PEF twice daily for 14 days and PEF variability, expressed as amplitude {\%} mean, was calculated. Subjects also underwent a standardized exercise challenge; BRE was defined as a maximal {\%} fall in FEV1 within 30 min after exercise. The mean (± SD) PEF variations in the symptomatic group and in the remission group were 12.10 ± 6.35{\%} and 10.02 ± 4.73{\%}, respectively, which were significantly higher than that (5.94 ± 2.44{\%}) of the control group. On the other hand, the degree of BRE (7.36 ± 3.85{\%}) in the remission group was significantly lower than that (22.31 ± 10.50{\%}) of the symptomatic group, and similar to that (5.98 ± 2.70{\%}) of the control group. Methacholine hyperresponsiveness in asthma remission during adolescence is associated with increased PEF variability but not with increased BRE.",
keywords = "Adolescence, Asthma, Bronchial hyperresponsiveness, Clinical remission, Exercise challenge, Peak expiratory flow variability",
author = "Young, {Yull Koh} and Hee Kang and Young Yoo and Jinho Yu and Kyu, {Min Nah} and Chang, {Keun Kim}",
year = "2005",
month = "3",
day = "29",
doi = "10.1081/JAS-200028014",
language = "English",
volume = "42",
pages = "17--23",
journal = "Journal of Asthma",
issn = "0277-0903",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Peak expiratory flow variability and exercise responsiveness in methacholine-hyperresponsive adolescents with asthma remission

AU - Young, Yull Koh

AU - Kang, Hee

AU - Yoo, Young

AU - Yu, Jinho

AU - Kyu, Min Nah

AU - Chang, Keun Kim

PY - 2005/3/29

Y1 - 2005/3/29

N2 - The aim of this study was to investigate whether bronchial hyperresponsiveness in adolescents with long-term asthma remission is associated with increased peak expiratory flow (PEF) variability and/or increased bronchial response to exercise (BRE). Twenty-nine adolescents with asthma remission (neither symptoms nor any medication used during the previous two years), but with persistent methacholine hyperresponsiveness (PC20 < 18 mg/mL; remission group), 29 methacholine PC20-matched adolescents with symptomatic asthma (symptomatic group), and 20 healthy subjects (control group) were studied. Subjects recorded PEF twice daily for 14 days and PEF variability, expressed as amplitude % mean, was calculated. Subjects also underwent a standardized exercise challenge; BRE was defined as a maximal % fall in FEV1 within 30 min after exercise. The mean (± SD) PEF variations in the symptomatic group and in the remission group were 12.10 ± 6.35% and 10.02 ± 4.73%, respectively, which were significantly higher than that (5.94 ± 2.44%) of the control group. On the other hand, the degree of BRE (7.36 ± 3.85%) in the remission group was significantly lower than that (22.31 ± 10.50%) of the symptomatic group, and similar to that (5.98 ± 2.70%) of the control group. Methacholine hyperresponsiveness in asthma remission during adolescence is associated with increased PEF variability but not with increased BRE.

AB - The aim of this study was to investigate whether bronchial hyperresponsiveness in adolescents with long-term asthma remission is associated with increased peak expiratory flow (PEF) variability and/or increased bronchial response to exercise (BRE). Twenty-nine adolescents with asthma remission (neither symptoms nor any medication used during the previous two years), but with persistent methacholine hyperresponsiveness (PC20 < 18 mg/mL; remission group), 29 methacholine PC20-matched adolescents with symptomatic asthma (symptomatic group), and 20 healthy subjects (control group) were studied. Subjects recorded PEF twice daily for 14 days and PEF variability, expressed as amplitude % mean, was calculated. Subjects also underwent a standardized exercise challenge; BRE was defined as a maximal % fall in FEV1 within 30 min after exercise. The mean (± SD) PEF variations in the symptomatic group and in the remission group were 12.10 ± 6.35% and 10.02 ± 4.73%, respectively, which were significantly higher than that (5.94 ± 2.44%) of the control group. On the other hand, the degree of BRE (7.36 ± 3.85%) in the remission group was significantly lower than that (22.31 ± 10.50%) of the symptomatic group, and similar to that (5.98 ± 2.70%) of the control group. Methacholine hyperresponsiveness in asthma remission during adolescence is associated with increased PEF variability but not with increased BRE.

KW - Adolescence

KW - Asthma

KW - Bronchial hyperresponsiveness

KW - Clinical remission

KW - Exercise challenge

KW - Peak expiratory flow variability

UR - http://www.scopus.com/inward/record.url?scp=14944357688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944357688&partnerID=8YFLogxK

U2 - 10.1081/JAS-200028014

DO - 10.1081/JAS-200028014

M3 - Article

VL - 42

SP - 17

EP - 23

JO - Journal of Asthma

JF - Journal of Asthma

SN - 0277-0903

IS - 1

ER -